Irkutsk
Ulan-Ude

Blagoveshchensk
Chita
Yakutsk

Birobidzhan
Vladivostok
Khabarovsk

Magadan
Yuzhno-Sakhalinsk

Anadyr
Petropavlovsk-
Kamchatsky
Moscow

This text is translated into Russian by google automatic human level neural machine.
EastRussia is not responsible for any mistakes in the translated text. Sorry for the inconvinience.
Please refer to the text in Russian as a source.

Japanese influenza drug will be tested on patients with coronavirus

Japanese influenza drug will be tested on patients with coronavirus
Photo: pixabay.com

The Ministry of Health of the Russian Federation has allowed a clinical trial of a Japanese drug against influenza in patients with coronavirus. Research will be held in 17 medical institutions in several regions of Russia.

According to TASS, referring to the press service of the Ministry, the medicine “Favipiravir” will be tested on patients hospitalized with a diagnosis of coronavirus. It is a chemical that is used as a propiviral preparation against various types of RNA viruses.

Previously, the drug was approved in Japan as an influenza, effective against severe infections caused by high viral load. Currently, pharmacists are producing substances and manufacturing the finished dosage form of the drug. After obtaining state approval, the drug will be released on the Russian market.

September 23: current information on coronavirus in the Far East
Digest of regional events and latest statistics